| Revenues | 9.32M |
| Cost of revenues | 8.61M |
| Gross profit | |
| Research and development | 2.63M |
| Selling, general, and administrative | 4.94M |
| Operating loss | -6.86M |
| Other income (expense), net | 5.12K |
| Interest expense | -384.92K |
| Nonoperating Income (Expense), Total | -379.8K |
| Loss from operations before provision for income taxes and noncontrolling interests | |
| Provision for income taxes | 46.95K |
| Net loss | -7.29M |
| Less - net income attributable to noncontrolling interests | |
| Net loss attributable to NeoStem, Inc. | |
| Preferred dividends | |
| Net loss attributable to NeoStem, Inc. common shareholders | -6.88M |
| Basic and diluted loss per share | -1.09 |
| Weighted average common shares outstanding | |